Revance Therapeutics, Inc. (RVNC)
Q4 2019 Results Earnings Conference Call
February 24, 2020, 4:30 am ET
Company Participants
Jeanie Herbert - Senior Director of Investor Relations and Corporate Communications
Mark Foley - President, Chief Executive Officer
Dustin Sjuts - Chief Commercial Officer of Aesthetics & Therapeutics
Toby Schilke - Chief Financial Officer
Abhay Joshi - Chief Operating Officer, President of R&D and Product Operations
Conference Call Participants
Annabel Samimy - Stifel
Ken Cacciatore - Cowen and Company
Holly Barra - Goldman Sachs
David Amsellem - Piper Sandler
Balaji Prasad - Barclays
Tim Lugo - William